Cargando…
Author Correction: Evaluating drug targets through human loss-of-function genetic variation
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064910/ https://www.ncbi.nlm.nih.gov/pubmed/33536628 http://dx.doi.org/10.1038/s41586-020-03177-5 |
| _version_ | 1783682237268492288 |
|---|---|
| author | Minikel, Eric Vallabh Karczewski, Konrad J. Martin, Hilary C. Cummings, Beryl B. Whiffin, Nicola Rhodes, Daniel Alföldi, Jessica Trembath, Richard C. van Heel, David A. Daly, Mark J. Schreiber, Stuart L. MacArthur, Daniel G. |
| author_facet | Minikel, Eric Vallabh Karczewski, Konrad J. Martin, Hilary C. Cummings, Beryl B. Whiffin, Nicola Rhodes, Daniel Alföldi, Jessica Trembath, Richard C. van Heel, David A. Daly, Mark J. Schreiber, Stuart L. MacArthur, Daniel G. |
| author_sort | Minikel, Eric Vallabh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8064910 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80649102021-05-05 Author Correction: Evaluating drug targets through human loss-of-function genetic variation Minikel, Eric Vallabh Karczewski, Konrad J. Martin, Hilary C. Cummings, Beryl B. Whiffin, Nicola Rhodes, Daniel Alföldi, Jessica Trembath, Richard C. van Heel, David A. Daly, Mark J. Schreiber, Stuart L. MacArthur, Daniel G. Nature Author Correction Nature Publishing Group UK 2021-02-03 2021 /pmc/articles/PMC8064910/ /pubmed/33536628 http://dx.doi.org/10.1038/s41586-020-03177-5 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Minikel, Eric Vallabh Karczewski, Konrad J. Martin, Hilary C. Cummings, Beryl B. Whiffin, Nicola Rhodes, Daniel Alföldi, Jessica Trembath, Richard C. van Heel, David A. Daly, Mark J. Schreiber, Stuart L. MacArthur, Daniel G. Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title | Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title_full | Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title_fullStr | Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title_full_unstemmed | Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title_short | Author Correction: Evaluating drug targets through human loss-of-function genetic variation |
| title_sort | author correction: evaluating drug targets through human loss-of-function genetic variation |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064910/ https://www.ncbi.nlm.nih.gov/pubmed/33536628 http://dx.doi.org/10.1038/s41586-020-03177-5 |
| work_keys_str_mv | AT minikelericvallabh authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT karczewskikonradj authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT martinhilaryc authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT cummingsberylb authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT whiffinnicola authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT rhodesdaniel authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT alfoldijessica authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT trembathrichardc authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT vanheeldavida authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT dalymarkj authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT schreiberstuartl authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation AT macarthurdanielg authorcorrectionevaluatingdrugtargetsthroughhumanlossoffunctiongeneticvariation |